Antiviral activity of carnosic acid against respiratory syncytial virus

Virology Journal

Volumn 10, Issue , 2013, Pages

  Shin, Han Bo ^a   Choi, Myung Soo ^a   Ryu, Byeol ^a   Lee, Na Rae ^a   Kim, Hye In ^a   Choi, Hye Eun ^a   Chang, Jun ^b   Lee, Kyung Tae ^a   Jang, Dae Sik ^a   Inn, Kyung Soo ^a  

^a Kyung Hee University   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

Anti hRSV activity; Carnosic acid; hRSV; Rosemarinus officinalis

Indexed keywords

ACETIC ACID ETHYL ESTER; ANTIOXIDANT; BETA INTERFERON; BETULIC ACID; CARNOSIC ACID; CATECHOL; INTERFERON; INTERLEUKIN 28; INTERLEUKIN 29; OLEANOLIC ACID; ROSMARINIC ACID; ROSMARINUS OFFICINALIS EXTRACT; URSOLIC ACID; VIRUS RNA;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CELL VIABILITY; CHEMICAL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN RESPIRATORY SYNCYTIAL PNEUMOVIRUS; INTERFERON PRODUCTION; LUNG INFECTION; QUANTITATIVE ANALYSIS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SYNTHESIS; ROSEMARY; VIRUS CULTURE; VIRUS GENE; VIRUS REPLICATION;

HUMAN RESPIRATORY SYNCYTIAL VIRUS; INFLUENZA A VIRUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; ROSMARINUS OFFICINALIS;

ANTIVIRAL AGENTS; CELL SURVIVAL; DITERPENES, ABIETANE; HUMANS; NEUTRALIZATION TESTS; PLANT EXTRACTS; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROSMARINUS; VIRAL PLAQUE ASSAY; VIRUS REPLICATION;

EID: 84885016168     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-303     Document Type: Article

References (34)

1. The burden of respiratory syncytial virus infection in young children. Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, Auinger P, Griffin MR, Poehling KA, Erdman D, et al. N Engl J Med 2009 360 588 598 10.1056/NEJMoa0804877 19196675
2. Respiratory syncytial virus infection in elderly and high-risk adults. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE, N Engl J Med 2005 352 1749 1759 10.1056/NEJMoa043951 15858184 (Pubitemid 40570923)
3. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, O'Brien KL, Roca A, Wright PF, Bruce N, et al. Lancet 2010 375 1545 1555 10.1016/S0140-6736(10) 60206-1 20399493
4. Diagnosis and management of bronchiolitis. American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis, Pediatrics 2006 118 1774 1793 17015575
5. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study. Hall CB, McBride JT, Walsh EE, Bell DM, Gala CL, Hildreth S, Ten Eyck LG, Hall WJ, N Engl J Med 1983 308 1443 1447 10.1056/NEJM198306163082403 6343860 (Pubitemid 13103444)
6. Ribavirin in ventilated respiratory syncytial virus bronchiolitis. A randomized, placebo-controlled trial. Guerguerian AM, Gauthier M, Lebel MH, Farrell CA, Lacroix J, Am J Respir Crit Care Med 1999 160 829 834 10.1164/ajrccm.160.3.9810013 10471604 (Pubitemid 29442016)
7. Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database. Law BJ, Wang EE, MacDonald N, McDonald J, Dobson S, Boucher F, Langley J, Robinson J, Mitchell I, Stephens D, Pediatrics 1997 99 7 9164803
8. Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. Pediatric Critical Study Group. Moler FW, Steinhart CM, Ohmit SE, Stidham GL, J Pediatr 1996 128 422 428 10.1016/S0022-3476(96)70294-9 8774517 (Pubitemid 26087548)
9. Antiviral amentoflavone from Selaginella sinensis. Ma SC, But PP, Ooi VE, He YH, Lee SH, Lee SF, Lin RC, Biol Pharm Bull 2001 24 311 312 10.1248/bpb.24.311 11256492 (Pubitemid 32237175)
10. Antiviral Chinese medicinal herbs against respiratory syncytial virus. Ma SC, Du J, But PP, Deng XL, Zhang YW, Ooi VE, Xu HX, Lee SH, Lee SF, J Ethnopharmacol 2002 79 205 211 10.1016/S0378-8741(01)00389-0 11801383 (Pubitemid 34136952)
11. Antiviral triterpenoids from the medicinal plant Schefflera heptaphylla. Li Y, Jiang R, Ooi LS, But PP, Ooi VE, Phytother Res 2007 21 466 470 10.1002/ptr.1962 17357972 (Pubitemid 46722421)
12. Antiviral effect of cimicifugin from Cimicifuga foetida against human respiratory syncytial virus. Wang KC, Chang JS, Lin LT, Chiang LC, Lin CC, Am J Chin Med 2012 40 1033 1045 10.1142/S0192415X12500760 22928833
13. Supercritical fluid extraction of natural antioxidants from rosemary: comparison with liquid solvent sonication. Tena MT, Valcarcel M, Hidalgo PJ, Ubera JL, Anal Chem 1997 69 521 526 10.1021/ac960506t 21639201 (Pubitemid 27101320)
14. Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. al-Sereiti MR, Abu-Amer KM, Sen P, Indian J Exp Biol 1999 37 124 130 10641130 (Pubitemid 29103965)
15. Antibacterial activity of the essential oil from Rosmarinus officinalis and its major components against oral pathogens. Bernardes WA, Lucarini R, Tozatti MG, Flauzino LG, Souza MG, Turatti IC, Silva ML A e, Martins CH, da Silva Filho AA, Cunha WR, Z Naturforsch C 2010 65 588 593 21138060
16. In vitro antimicrobial and antioxidant activity of commercial rosemary extract formulations. Klancnik A, Guzej B, Kolar MH, Abramovic H, Mozina SS, J Food Prot 2009 72 1744 1752 19722413
17. Antioxidant and antigenotoxic effects of rosemary (Rosmarinus officinalis L.) extracts in Salmonella typhimurium TA98 and HepG2 cells. Zegura B, Dobnik D, Niderl MH, Filipic M, Environ Toxicol Pharmacol 2011 32 296 305 10.1016/j.etap.2011.06.002 21843811
18. Antioxidative constituents of Rosmarinus officinalis and Salvia officinalis. II. Isolation of carnosic acid and formation of other phenolic diterpenes. Schwarz K, Ternes W, Z Lebensm Unters Forsch 1992 195 99 103 10.1007/BF01201766 1529648
19. Carnosic acid inhibits the growth of ER-negative human breast cancer cells and synergizes with curcumin. Einbond LS, Wu HA, Kashiwazaki R, He K, Roller M, Su T, Wang X, Goldsberry S, Fitoterapia 2012 83 1160 1168 10.1016/j.fitote.2012.07.006 22828666
20. Antiproliferation effect of Rosemary (Rosmarinus officinalis) on human ovarian cancer cells in vitro. Tai J, Cheung S, Wu M, Hasman D, Phytomedicine 2012 19 436 443 10.1016/j.phymed.2011.12.012 22325591
21. Carnosic acid modulates Akt/IKK/NF-kappaB signaling by PP2A and induces intrinsic and extrinsic pathway mediated apoptosis in human prostate carcinoma PC-3 cells. Kar S, Palit S, Ball WB, Das PK, Apoptosis 2012 17 735 747 10.1007/s10495-012-0715-4 22453599
22. Antibacterial and resistance modifying activity of Rosmarinus officinalis. Oluwatuyi M, Kaatz GW, Gibbons S, Phytochemistry 2004 65 3249 3254 10.1016/j.phytochem.2004.10.009 15561190 (Pubitemid 39550392)
23. Supercritical fluid extracts of rosemary leaves exhibit potent anti-inflammation and anti-tumor effects. Peng CH, Su JD, Chyau CC, Sung TY, Ho SS, Peng CC, Peng RY, Biosci Biotechnol Biochem 2007 71 2223 2232 10.1271/bbb.70199 17827696 (Pubitemid 350113116)
24. Carnosic acid protects neuronal HT22 Cells through activation of the antioxidant-responsive element in free carboxylic acid- and catechol hydroxyl moieties-dependent manners. Satoh T, Izumi M, Inukai Y, Tsutsumi Y, Nakayama N, Kosaka K, Shimojo Y, Kitajima C, Itoh K, Yokoi T, Shirasawa T, Neurosci Lett 2008 434 260 265 10.1016/j.neulet.2008.01.079 18329808
25. Inhibitory effect of carnosic acid on HIV-1 protease in cell-free assays [corrected]. Paris A, Strukelj B, Renko M, Turk V, Pukl M, Umek A, Korant BD, J Nat Prod 1993 56 1426 1430 10.1021/np50098a031 8229021 (Pubitemid 23267995)
26. Viral degradasome hijacks mitochondria to suppress innate immunity. Goswami R, Majumdar T, Dhar J, Chattopadhyay S, Bandyopadhyay SK, Verbovetskaya V, Sen GC, Barik S, Cell Res 2013 23 1025 1042 10.1038/cr.2013.98 23877405
27. Multiple functional domains and complexes of the two nonstructural proteins of human respiratory syncytial virus contribute to interferon suppression and cellular location. Swedan S, Andrews J, Majumdar T, Musiyenko A, Barik S, J Virol 2011 85 10090 10100 10.1128/JVI.00413-11 21795342
28. Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I. Ling Z, Tran KC, Teng MN, J Virol 2009 83 3734 3742 10.1128/JVI.02434-08 19193793
29. Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]. Spann KM, Tran KC, Chi B, Rabin RL, Collins PL, J Virol 2004 78 4363 4369 10.1128/JVI.78.8.4363-4369.2004 15047850 (Pubitemid 38437240)
30. Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription. Fearns R, Collins PL, J Virol 1999 73 5852 5864 10364337 (Pubitemid 29274872)
31. Evaluation of protective efficacy of respiratory syncytial virus vaccine against A and B subgroup human isolates in Korea. Jang JE, Lee JB, Kim KH, Park SM, Shim BS, Cheon IS, Song MK, Chang J, PLoS One 2011 6 23797 10.1371/journal.pone.0023797 21915262
32. A simplified plaque assay for respiratory syncytial virus-direct visualization of plaques without immunostaining. McKimm-Breschkin JL, J Virol Methods 2004 120 113 117 10.1016/j.jviromet.2004.02.020 15234816 (Pubitemid 38968662)
33. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, Carnero E, Farzan M, Inoue S, Jung JU, Garcia-Sastre A, Cell Host Microbe 2009 5 439 449 10.1016/j.chom.2009.04.006 19454348
34. Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. Johnson S, Oliver C, Prince GA, Hemming VG, Pfarr DS, Wang SC, Dormitzer M, O'Grady J, Koenig S, Tamura JK, et al. J Infect Dis 1997 176 1215 1224 10.1086/514115 9359721 (Pubitemid 27460986)